4//SEC Filing
Loxo Oncology, Inc. 4
Accession 0001140361-15-029148
CIK 0001581720operating
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:20 PM ET
Size
5.4 KB
Accession
0001140361-15-029148
Insider Transaction Report
Form 4
Naider Avi Z.
Director
Transactions
- Award
Director Stock Option (right to buy)
2015-07-28+7,812→ 7,812 totalExercise: $20.91Exp: 2025-07-27→ Common Stock (7,812 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Loxo Oncology, Inc.
CIK 0001581720
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001581720
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:20 PM ET
- Size
- 5.4 KB